Option delistings effective December 23rd include Pieris Pharmaceuticals (PVLA), Nanostring Technologies, Inc. (NSTGQ), NaaS Technology (NAAS), ROUNDHILL DAILY INVERSE MAGNIFICENT SEVEN ETF (MAGQ), Merrimack Pharmaceuticals Inc (MACK), Cue Health Inc (HLTHQ), Galera Therapeutics Inc (GRTX), DermTech Inc (DMTKQ), Cidara Therapeutics (CDTX), Nuburu, Inc. (BURU), Atara Biotherapeutics (ATRA), and RCM Technologies (RCMT).
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PVLA: